CMI_LatestReportOrientedBlogs

  The next big hope in the fight against advanced cancers lies with Anti-body Coupled T Receptor Therapy . This technology combines genetic engineering with traditional therapy to create an efficient new cancer fighting agent. There are at least ten types of receptor therapies in the anti-cancer market, with an additional four developing over the next few years. Most of them involve using antibodies to target specific cancer cells, such as leukemia or melanoma. Others involve injecting antibodies directly into a tumor or a cancerous site to kill the root cause. One new class of drugs called systemic antigens is being developed for this purpose. These may provide the basis for a new anti-cellulite, anti-thrombotic, and anti-viral class of drugs in the future. For instance, in August 2021, Salipro Biotech partnered with the European Molecular Biology Laboratory, Germany to explore the efficacy of Salipro solutions in mAb (monoclonal antibody) discovery. The company has conducted studies

  Alveolar Rhabdomyosarcoma Treatment often includes surgery, chemotherapy, and radiation therapy (radiotherapy). Moreover, the treatment of rhabdomyosarcoma has greatly improved the care of patients over the past few decades. Around 80% of patients with rhabdomyosarcoma (low-risk) can now be cured. Alveolar rhabdomyosarcoma (ARMS) refers to one subtype of the rhabdomyosarcoma family of soft tissue tumors. While, rhabdomyosarcoma is a rare type of cancer that forms in soft tissue; may occur at any age, often affects children. Alveolar Rhabdomyosarcoma Treatment , such as chemotherapy, is given by injection into a vein. In North America, drugs such as cyclophosphamide (Neosar, Clafen, Cytoxan,), dactinomycin (Cosmegen, Lyovac Cosmegen), and vincristine (Vincasar, Oncovin) are commonly used to treat rhabdomyosarcoma. This combination of drugs is often called Vincristine, actinomycin D, and cyclophosphamide (VAC), an abbreviation for a chemotherapy combination used to treat rhabdomyosarc

  Adenovirus Diagnostic Testing is done all over the world, including in regions such as Germany, Japan, and Mexico. Adenovirus diagnostic testing is administered to patients who are diagnosed with adenovirus. Adenoviruses are extremely common in children and they can cause serious illness if not detected and treated in time. Currently, the most widely used adenovirus diagnostic testing types are the use of PCR-based antigen identification tests and polymerase chain reactions (PCR). There are several problems associated with PCR-based tests such as low sensitivity and false-positive results. In addition, PCR amplifies the genetic material within the virus and does not allow for the generation of template clones from non-genetic DNA. The use of an antigen-specific fluorescent marker probe has recently emerged as one of the more effective ways of Adenovirus Diagnostic Testing . These tests require one or more DNA probes to be randomly introduced into the patient's bloodstream. Based

  5G Infrastructure refers to the fifth generation cellular network that is meant to deliver higher multi-Gbps peak data speeds, more reliability, ultra low latency, massive network capacity, and a more uniform user experience to more users. Improved efficiency and higher performance empower new user experiences and connects new industries. 5G infrastructure is required for the functionality of fifth generation cellular networks. Moreover, it requires thousands of cell towers and antennae to provide uniform user experience to more users. 5G is a new network architecture that will greatly expand connectivity and support new kinds of services. There are over 130 commercial 5G agreements with unique communication service providers and 83 live 5G networks around the world. For example, in 2019, Verizon introduced 5G in parts of many cities with plans to have 5G in more than 30 U.S. Verizon currently offers 5G broadband internet, called 5G Home, in 52 cities, such as Sacramento CA, Houston

 Peripheral vascular disease (PVD) is narrowing of arteries outside brain and heart. Risk factors for the growth of PVD include, hypertension, obesity, diabetes, and smoking. Peripheral vascular products are employed for the treating these blocked arteries and remove the buildup plaque. Peripheral vascular stents, peripheral transluminal angioplasty balloon catheter and aortic stents would be the mostly used devices for the treating PVD. Growth in this market is majorly driven by the rapid growth in the geriatric population and the associated upsurge in the prevalence of peripheral vascular diseases, the approval of new and advanced products, and the rising incidence of diabetes. However, the option of alternative treatments and product failures and recalls would be the major factors which can be likely to restrain the growth with this Peripheral Vascular Devices Market during the forecast period. The global Peripheral Vascular Devices Market is estimated to take into account US$ 8,9

  Oilfield stimulation is the process undertaken for the recovery and improving the flow of hydrocarbons from drilling well. Oilfield stimulation chemicals market can be classified into gelling agents, friction reducers, surfactants, corrosion & scale inhibitors, acids, and others such as biocides and cross linkers.   The production of crude oil is driving the consumption of Oilfield Stimulation Chemicals Market , globally. Rise in the drilling of deeper wells is also one of the key reasons for the growth of the market. Growing demand for well stimulation processes offers great push to the oilfield stimulation chemicals market. It offers a wide range of opportunities to chemical suppliers as well as formulated oilfield chemical suppliers. Regulations related to the protection of surface water and ground water during seismic testing is hindering the growth of the oilfield services market. The oilfield operations of existing wells have now become difficult due to the introduction of

  Various strategies are leveraged by success-hungry players in The Global Hyperbaric Oxygen Therapy Devices Market. One of them is the thrust on research and development to come up with new or better products. Their focus is on building cost-effective medical devices that would see greater uptake. Strategic partnerships are also being undertaken by them to diversify product portfolios and gain greater share. Further, companies are shifting their gaze to developing countries that offer lucrative opportunities.   The global H yperbaric O xygen T herapy D evices M arket was valued at US$ 2255.3 million in 2018, and is expected to exhibit a CAGR of 6.6% over the forecast period (2019-2027).   Overall, the global hyperbaric oxygen therapy devices market is fragmented in nature on account of the presence of numerous small scale vendors. However, the global market is dominated by a handful of prominent players that have their operations worldwide.

  Hemostasis diagnostics are those devices that really help in the identification of hemostatic defects which leads to excessive bleeding. Hemostasis helps in the diagnosis of actual cause of these disorders with history and helps in the treatment. Hemostasis is just a mechanism followed by your body after getting injured, it decreases the blood loss and stop the blood flow. Hemostasis diagnostics market is segmented by product, test, end use and geography. Centered on product type, the global Hemostasis Diagnostics Market has been split into laboratory systems, consumables, point-of-care testing systems. Laboratory systems is further segmented into automated systems, semi-automated systems, manual systems. Hemostasis diagnostics help identify the hemostatic defects that cause excessive bleeding. Hemostasis is a process of slowing and stopping the blood flow to initiate wound healing after having a vascular injury and is the main element procedure acting in the very first line of acti

  Facial implants is a type of cosmetic surgery, which involves an advanced technology to improve a physical appearance in case of various abnormalities by birth or acquired such as cancer and accidents. The approach of facial implant basically refers to a type of surgical intervention where specially designed medical devices are placed inside the body to replace the damaged part and regain their appearance. Furthermore, medical devices for facial implants are designed by solid materials that are compatible with human tissues that further gives the damaged part a better and comprehensive look. Various parts such as chin, cheek and jaw can be enhanced by the help of implanting a medically constructed homologous products. There are no medical alternatives for facial implants that can reshape the cheeks or chin.   Global Facial Implants Market size was valued at USD 1.74 billion in 2014. Rising incidences of sports-related facial injuries and demand for minimally invasive surgeries for t

  Containers as a Service (type of container-based virtualization) can be an emerging technology by which vendors provide an entire framework to the users for managing and developing containers and applications. CaaS is majorly made for IT developers to control and run applications. The important thing factor fueling growth of the marketplace could be the increasing utilization of micro services. The rise of DevOps technology and containerization have helped revolutionize enterprise applications. However, some factors such as for example portability issues between severs, lack of tools required to control and monitor the container, hinders growth of the CaaS market. The major drivers for Container-as-a-Service Market could be the increasing usage of micro services, the rise of DevOps, and containerization has changed enterprises applications. Enterprises has started implementing hybrid cloud with infrastructure for virtual resources they choose advanced container platform.